TriSalus Life Sciences, Inc. TLSI Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s allowance for doubtful accounts receivable (current)?
- TriSalus Life Sciences, Inc. (TLSI) reported allowance for doubtful accounts receivable (current) of $76K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s allowance for doubtful accounts receivable (current) changed year-over-year?
- TriSalus Life Sciences, Inc.'s allowance for doubtful accounts receivable (current) decreased by 48.6% year-over-year, from $148K to $76K.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.